Company: PCRX
Filing Date: 2025-04-18
Form Type: DEFA14A
Source: 0001396814-25-000053
Chunk: 5

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-18
Form: DEFA14A
Chunk 5
---
o Bigal on August 19, 2024 ; Form 4, filed by Daryl Gaugler on September 13, 2024 ; Form 3, filed by Shawn Cross on October 23, 2024 ; Form 4, filed by Shawn Cross on November 5, 2024 ; Form 4, filed by Daryl Gaugler on December 16, 2024 ; Form 4, filed by Lauren Riker on January 6, 2025 ; Form 4, filed by Daryl Gaugler on January 6, 2025 ; Form 4, filed by Jonathan Slonin on January 6, 2025 ; Form 4, filed by Frank D. Lee on January 6, 2025 ; Form 3, filed by Brendan Teehan on January 28, 2025 ; Form 4, filed by Lauren Riker on February 4, 2025 ; Form 4, filed by Brendan Teehan on February 4, 2025 ; Form 4, filed by Frank D. Lee on February 4, 2025 ; Form 4, filed by Kristen Williams on February 4, 2025 ; and Form 4, filed by Jonathan Slonin on February 4, 2025 . Additional information can also be found in Pacira’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025 . Details concerning potential participants in the solicitation, including Pacira’s director nominees for election at the 2025 Annual Meeting, will also be included in the 2025 Proxy Statement. These documents, including the definitive 2025 Proxy Statement (and any amendments or supplements thereto) and other documents filed by Pacira with the SEC, are, or will be when filed, available for no charge on the SEC’s website at http://www.sec.gov and on Pacira’s investor relations website at https://investor.pacira.com.